Skip to content

Evaluation of the effectiveness of soybean lettuce mixture powder for improving menopausal symptoms

Evaluation of the effectiveness of soybean lettuce mixture powder for improving menopausal symptoms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007316
Enrollment
40
Registered
2022-05-19
Start date
2022-03-14
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Participants are randomly offered to a soybean lettuce mixed extract or placebo for 1 tablet at a time, 4 times a day (after each meal and bed). When a participant starts to take,

Sponsors

Wonkwang University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult women aged 45 or older and under 70 years old, who have reached menopause, must have menopause syndrome, and have a Kupperman index of 15 or higher, can participate.

Exclusion criteria

Exclusion criteria: Exclusion criteria were as follows: those who had undergone HRT within 6 weeks or had surgically menopause, patients who were contraindicated in hormone therapy, patients with acute and severe cardiovascular diseases(heart failure, myocardial infarction, and stroke), those with serious liver function abnormalities, those with a history of clinically significant hypersensitivity to drugs and health functional foods, those with a history of psychiatric treatment within 2 months prior to screening, those with a history of drug or alcohol abuse ruler.

Design outcomes

Primary

MeasureTime frame
Kupperman index

Secondary

MeasureTime frame
total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), non-HDL-cholesterol (NonHDL-C), ALT, AST, gamma -glutamyl transferase, BUN, creatinine, glucose, and high sensitivity C-reactive protein, serum thyroid-stimulating hormone (TSH), estradiol, Follicle-stimulating hormone (FSH) levels

Countries

Korea, Republic of

Contacts

Public ContactA Lum Han

Wonkwang University Hospital

qibosarang@naver.com+82-63-859-1301

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026